Pharmaceuticals News and Research

RSS
New cancer drug Tarceva - a breakthrough with significant survival benefit in patients with advanced lung cancer

New cancer drug Tarceva - a breakthrough with significant survival benefit in patients with advanced lung cancer

Men encouraged to 'pop down to their local' more often

Men encouraged to 'pop down to their local' more often

New Jersey announces automatic enrollment in new medicare drug discount program

New Jersey announces automatic enrollment in new medicare drug discount program

Spice turmeric corrects the cystic fibrosis defect

Spice turmeric corrects the cystic fibrosis defect

Canadian doctors oblivious to costs of prescribed drugs

Canadian doctors oblivious to costs of prescribed drugs

CellCept linked to reduced cancer incidence

CellCept linked to reduced cancer incidence

IVAX announces intention to revise offer for Polfa Kutno

IVAX announces intention to revise offer for Polfa Kutno

Potential new drug may slow the progression of the Parkinson's disease

Potential new drug may slow the progression of the Parkinson's disease

SSRI antidepressants may be unsuitable for children

SSRI antidepressants may be unsuitable for children

Research into link between oceans and human health

Research into link between oceans and human health

HHS approves first-ever multi-state purchasing pools for Medicaid drug programs

HHS approves first-ever multi-state purchasing pools for Medicaid drug programs

Clinical trial of curcumin in people with cystic fibrosis

Clinical trial of curcumin in people with cystic fibrosis

SkyePharma delivery technologies for respiratory drugs to feature at two international conferences

SkyePharma delivery technologies for respiratory drugs to feature at two international conferences

Schering-Plough submits Japanese application for hepatitis C drug

Schering-Plough submits Japanese application for hepatitis C drug

FDA approval for drug to treat attention deficit hyperactivity disorder

FDA approval for drug to treat attention deficit hyperactivity disorder

Doctors from the University of Edinburgh and local intensive care units have linked to fight an antibiotic-resistant infection which attacks some hospital patients.

Doctors from the University of Edinburgh and local intensive care units have linked to fight an antibiotic-resistant infection which attacks some hospital patients.

FDA approves new breakthrough Parkinson's drug

FDA approves new breakthrough Parkinson's drug

Pierre Pettigrew outlines plan of action for health care reforms

Pierre Pettigrew outlines plan of action for health care reforms

Drug importation a 'counterfeit issue'

Drug importation a 'counterfeit issue'

Altana starts legal action to fight generic drug competition

Altana starts legal action to fight generic drug competition

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.